BioSpace News Archive

Drug Development

Idorsia Drug Flops in Fabry Disease, Program’s Future Pending

Its Phase III MODIFY study had hoped to find a positive effect of its oral substrate reduction therapy lucerastat on adult patients who have been diagnosed with Fabry disease.

October 11, 2021
·
2 min read
·
Vanessa Doctor, RN
FDA

FDA Greenlights Enzyvant Drug Rethymic for Ultra-Rare Pediatric Disease

The incidence of congenital athymia is about 17 to 24 lives births each year in the U.S. The therapy is a one-time regenerative tissue-based therapy.

October 11, 2021
·
3 min read
·
Mark Terry
Business

GSK Continues to Switch Up Scenery in Advance of Upcoming Demerger

The scenery will continue to change for GlaxoSmithKline as the company’s planned demerger looms on the horizon. On Monday, GSK gave a glimpse of where the companies will call home post-split.

October 11, 2021
·
2 min read
·
Ellen Camacho
Drug Development

OXURION - Positive Phase 2 Part A THR-149 data shared at the America Society of Retinal Specialists (ASRS) Annual Scientific Meeting

Oxurion NV is delighted to announce that further characterization of the BCVA data from the previously reported Part A portion of the Phase 2 study of THR-149 was shared at the American Society for Retinal Specialists Annual Scientific Meeting.

October 11, 2021
·
5 min read
Business

Ipsen appoints Mari Scheiffele as EVP and President, Specialty Care International

Ipsen announced the appointment of Mari Scheiffele as EVP and President, Specialty Care International, effective November 1st 2021.

October 11, 2021
·
6 min read
Drug Development

Basilea presents preclinical data on synergy between derazantinib and paclitaxel in gastric tumor models at ANE Conference

Basilea Pharmaceutica Ltd. announced the presentation of data from preclinical studies demonstrating synergistic anti-tumor effects in a number of gastric cancer models for the combination of Basilea’s fibroblast growth factor receptor inhibitor, derazantinib, with the chemotherapy paclitaxel.

October 11, 2021
·
7 min read
PACS and RIS Market to Rise on the Back of Advent of Cloud-based PACS Solutions in Near Future

Transparency Market Research has published a new report titled, PACS and RIS Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

October 11, 2021
·
6 min read
Lyme Disease Diagnostics Market: Serological Test to Dominate Global Market

According to the report, the global Lyme disease diagnostics market was valued at ~US$ 2 Bn in 2020 and is projected to expand at a CAGR of 4% from 2021 to 2031.

October 11, 2021
·
7 min read
Laboratory Freezers Market: The Blood Banks Segment is Expected to be Driven by High Demand for Blood Components

Laboratory freezers are used in laboratories and in research laboratories. These freezers have to meet specific requirements with regards to safety and temperature consistency.

October 11, 2021
·
6 min read
IVF Services Market: High Adoption of IVF Procedures in Both Urban and Rural Areas to Drive the Market

The IVF services market is witnessing an upsurge mainly because of the high success rates of conception associated with IVF.

October 11, 2021
·
5 min read